id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0047-0004,FDA,FDA-2010-E-0047,FDA/CDER to US Patent and Trademark Office - Letter,Other,Letter(s),2011-08-17T04:00:00Z,2011,8,2011-08-17T04:00:00Z,,2011-08-17T15:52:39Z,,0,0,0900006480ee3353
FDA-2010-E-0047-0003,FDA,FDA-2010-E-0047,Determination of Regulatory Review Period for Purposes of Patent Extension; ILARIS,Notice,N-Notice,2010-12-09T05:00:00Z,2010,12,2010-12-09T05:00:00Z,,2024-11-07T22:27:57Z,2010-30992,1,0,0900006480bb2d66
FDA-2010-E-0047-0002,FDA,FDA-2010-E-0047,FDA/CDER to U.S. Patent Trademark Office - Letter,Other,LET-Letter,2010-10-28T04:00:00Z,2010,10,2010-10-28T04:00:00Z,,2010-10-28T19:57:55Z,,0,0,0900006480b7a01c
FDA-2010-E-0047-0001,FDA,FDA-2010-E-0047,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-25T04:00:00Z,2010,3,2010-03-25T04:00:00Z,,2013-07-27T23:13:10Z,,0,0,0900006480ac76f7